Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022

March 2023 | Volume 22 | Issue 3 | 310 | Copyright © March 2023


Published online February 13, 2023

Jennifer Jacobs BSa, Jamie Lebhar BMEa, Carrie Diamond BAa, Chandler W. Rundle MDb, Christopher Stamey MDa,b

aDuke University School of Medicine, Durham, NC
bDuke University Health System, Department of Dermatology, Durham, NC



Limitations of this study include low numbers of clinical trials for specific skin conditions. Further limitations include the exclusion of trials that were incomplete or did not report their findings publicly. Furthermore, this study did not include information on location of clinical trials in the US.

DISCUSSION

There is limited data available in clinical trials with respect to race, ethnicity, and FST and SOC needs to be adequately represented and reported in research regarding dermatologic skin conditions to ensure equality and equity in dermatologic care.

DISCLOSURES

The authors of this manuscript have no conflicts of interest to declare.

REFERENCES

  1. Omar D, Syder N, Brown-Korsah JB, et al. Racial and ethnic disparities in clinical research and the dermatology workforce. J Am Acad Dermatol. 2022;4:S0190-9622(22)00544-8.
  2. Barve A, Shah M, Sheth P. Skin of color images in pediatric dermatology textbooks. Pediatr Dermatol. 2021;38 (Suppl 2):144-5.
  3. Rambhia PH, Yan BY, Barilla S, et al. Racial and ethnic diversity in clinical trials of laser treatments for scars. J Am Acad Dermatol. 2022;87(5):1178-1179.
  4. Okeke CAV, Perry JD, Simmonds FC, et al. Clinical trials and skin of color: The example of hidradenitis suppurativa. Dermatology. 2022;238(1):180-184.
  5. Charrow A, Xia FD, Joyce C, et al. Diversity in dermatology clinical trials: A systematic review. JAMA Dermatol. 2017;153(2):193-198.
  6. JAMA Dermatol. 2017;153(2):193-198.

AUTHOR CORRESPONDENCE

Christopher Stamey MD Christopher.stamey@duke.edu
Close Menu